Pérez Dorado Group
Dept. of Crystallography and Structural Biology, IQF-CSIC
Dr. J. Inmaculada Pérez Dorado
jiperez@iqfr.csic.es
Dept. of Crystallography and Structural Biology
Inst. Physical Chemistry Blas Cabrera, CSIC
Serrano 119, E-28006 Madrid, Spain
Telf.: +34 91 561 94 00 / ext. 442055
(direct no. 91 3891696)
Fax: +34 91 564 24 31
My profile through Google Scholar
My profile through ResearchGate
Short CV
Personal sketch
Personal data
-
Research Fellow, 2020-present (Spanish National Research Council, CSIC)
-
Senior Scientist in Structural Biology, 2018-2020 (Evotec UK Ltd, Abingdon, UK)
-
Research Associate, 2013-2017 (Imperial College London, London, UK)
-
Postdoctoral Researcher, 2012-2013 (Lab. of Molecular Biology-Medical Research Council, Cambridge, UK)
-
Long-Term Postdoctoral FEBS Fellow, 2009-2012 (Lab. of Molecular Biology-Medical Research Council, Cambridge, UK)
-
Postdoctoral Researcher, 2009 (Lab. of Molecular Biology-Medical Research Council, Cambridge, UK)
-
Ph.D. in Biochemistry, 2008 (Univ. Complutense de Madrid, Madrid, Spain)
-
Predoctoral Fellow I3P-CSIC, 2005-2008 (Spanish National Research Council, CSIC)
-
Bruker-Nonius Research Fellow, 2002-2004 (Spanish National Research Council, CSIC)
-
Ms. Sci. in Biochemistry 2001 (Univ. Complutense de Madrid, Madrid, Spain)
Professional experience
-
Molecular Biology and purification of recombinant proteins
-
Structural biology techniques with strongest background in protein crystallography
-
Fragment screening and drug discovery using X-ray crystallography
Research interest
My career focuses in the functional/structural characterization of proteins involved in host-pathogen interactions and membrane trafficking processes linked to human disease as main topic, giving also important attention to other fundamental events such as redox processes. At present my main interest centers in the structural and functional characterization of virulence factors from Mycobacterium tuberculosis, the causative agent of human tuberculosis. My goal is understanding the molecular basis governing host-pathogen interactions not fully understood so far in this infectious agent, information that may lead to find new drug targets and developing new strategies to fight tuberculosis.